Drugs / hCG
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04064840 Comparator | Sep 2019 → Sep 2024 overdue | infertility disorder | The University of Hong Kong | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04064840 ↗ |
| Route | Subcutaneous | “recombinant hCG 0.25mg and decapeptyl 0.2mg will be injected subcutaneously” NCT04064840 ↗ |